[Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D001157:Arterial Occlusive Diseases / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007383:Intermittent Claudication / Q000188:drug therapy; D002537:Intracranial Arteriosclerosis / Q000188:drug therapy*; D007659:Ketones / Q000627:therapeutic use; D007871:Leg Ulcer / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D010292:Paresthesia / Q000188:drug therapy; D014665:Vasodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014970:Xanthines / Q000627:therapeutic use*
D007659:Ketones; D014665:Vasodilator Agents; D014970:Xanthines
Erfahrungen mit Trental bei peripheren Durchblutungsstörungen und zerebrovaskulärer Insuffizienz.